BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:40:00 PM | Browse: 1354 | Download: 1407
 |
Received |
|
2013-06-02 17:52 |
 |
Peer-Review Started |
|
2013-06-03 13:47 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-07-21 16:20 |
 |
Revised |
|
2013-08-02 14:48 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-08-08 19:27 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-08-09 01:17 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
2013-08-15 17:43 |
 |
Typeset the Manuscript |
|
2013-09-16 16:27 |
 |
Publish the Manuscript Online |
|
2013-10-18 17:02 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Toru Ishikawa |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Toru Ishikawa, MD, PhD, Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, 280-7 Teraji, Niigata 950-1104, Japan. toruishi@ngt.saiseikai.or.jp |
| Key Words |
Hepatocellular carcinoma; Intrahepatic distant recurrence; Multicentric recurrence; Hepatitis C virus; Interferon; Arterial chemotherapy |
| Core Tip |
Recent advances in treatment modalities have improved the survival rate of patients with hepatocellular carcinoma (HCC). However, long-term outcomes of patients with HCC remain unsatisfactory because of the high incidence of distant intrahepatic recurrence, multicentric recurrence and low survival rates. In particular, hepatitis C virus-related hepatocellular carcinoma has a much higher recurrence rate than other cancers. In this article, we describe the prognosis of recurrent HCC and the therapeutic strategies for reducing recurrent HCC. |
| Publish Date |
2013-10-18 17:02 |
| Citation |
Ishikawa T. Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma. World J Gastroenterol 2013; 19(37): 6127-6130 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i37/6127.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i37.6127 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.